English

Obagi Medical Products, Inc.

EDGAR

Annual report amendment (10-K/A) · filed 2013-04-24

28 filing records in this dataset, filed from 2007-03-15 to 2013-04-24. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

30.3 million Unit12

2012 Q4 · Unit12

Exact inputs and evidence

Revenue: 30271000 Unit12 Source

Cash and cash equivalents: 34.6 million Unit12 2012-12-31 Source
Exact value

34552000 Unit12
Long-term debt including current maturities: Not available
Shares outstanding: 17.4 million Unit1 2012-12-31 Source
Exact value

17427471 Unit1

Reported share-count change

-6.72% · -1.26 million Unit1

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

18682721 Unit1 · 2011-12-31· Source
17427471 Unit1 · 2012-12-31· Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2013-04-24.

Financial data available through: 2012-12-31.

Coverage by financial measure

Revenue: 4 of 11 periods available· newest 2012-12-31
Operating income: 4 of 11 periods available· newest 2012-12-31
Net income: 4 of 11 periods available· newest 2012-12-31
Operating cash flow: 4 of 11 periods available· newest 2012-12-31
Capital expenditure: 4 of 11 periods available· newest 2012-12-31
Total assets: 3 of 11 periods available· newest 2012-12-31
Total liabilities: 3 of 11 periods available· newest 2012-12-31
Current assets: 3 of 11 periods available· newest 2012-12-31
Current liabilities: 3 of 11 periods available· newest 2012-12-31
Cash and cash equivalents: 5 of 11 periods available· newest 2012-12-31
long term debt: No compatible figures in this window
Shares outstanding: 3 of 11 periods available· newest 2012-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+5.8%

Prior period

Unit12 114.11 million

2011-01-01 – 2011-12-31
Current period

Unit12 120.68 million

2012-01-01 – 2012-12-31

Exact inputs and evidence

120678000 − 114108000 = 6570000 Unit12

114108000 Unit12 · 2011-01-01 – 2011-12-31
Inspect prior input Prior source
120678000 Unit12 · 2012-01-01 – 2012-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Obagi Medical Products, Inc. · 2012-12-31 Obagi Medical Products, Inc. (edgar:1375247) Year-over-year change in Revenue: 6570000 Unit12 Concept: fundies:Revenue Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T18:42:31Z Snapshot: 2fbca020a3b1a3920ec51a910fa98a0db8635d0ebbb06756403649f6e697ad49 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1375247?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 120678000 Unit12 (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1375247/000137524713000002/ompi-20121231.xml#1305018 Filing: 000137524713000002 Input fundies:Revenue: 114108000 Unit12 (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1375247/000137524713000002/ompi-20121231.xml#1301942 Filing: 000137524713000002
The citation records this snapshot. The page link may show a newer release later.
Net income
+66%

Prior period

Unit12 10.02 million

2011-01-01 – 2011-12-31
Current period

Unit12 16.64 million

2012-01-01 – 2012-12-31

Exact inputs and evidence

16638000 − 10020000 = 6618000 Unit12

10020000 Unit12 · 2011-01-01 – 2011-12-31
Inspect prior input Prior source
16638000 Unit12 · 2012-01-01 – 2012-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Obagi Medical Products, Inc. · 2012-12-31 Obagi Medical Products, Inc. (edgar:1375247) Year-over-year change in Net income: 6618000 Unit12 Concept: fundies:NetIncome Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T18:42:31Z Snapshot: 2fbca020a3b1a3920ec51a910fa98a0db8635d0ebbb06756403649f6e697ad49 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1375247?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 16638000 Unit12 (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1375247/000137524713000002/ompi-20121231.xml#1032861 Filing: 000137524713000002 Input fundies:NetIncome: 10020000 Unit12 (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1375247/000137524713000002/ompi-20121231.xml#1032727 Filing: 000137524713000002
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+5.3%

Prior period

Unit12 19.39 million

2011-01-01 – 2011-12-31
Current period

Unit12 20.42 million

2012-01-01 – 2012-12-31

Exact inputs and evidence

20422000 − 19392000 = 1030000 Unit12

19392000 Unit12 · 2011-01-01 – 2011-12-31
Inspect prior input Prior source
20422000 Unit12 · 2012-01-01 – 2012-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Obagi Medical Products, Inc. · 2012-12-31 Obagi Medical Products, Inc. (edgar:1375247) Year-over-year change in Operating cash flow: 1030000 Unit12 Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T18:42:31Z Snapshot: 2fbca020a3b1a3920ec51a910fa98a0db8635d0ebbb06756403649f6e697ad49 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1375247?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 20422000 Unit12 (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1375247/000137524713000002/ompi-20121231.xml#1032362 Filing: 000137524713000002 Input fundies:OperatingCashFlow: 19392000 Unit12 (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1375247/000137524713000002/ompi-20121231.xml#1032130 Filing: 000137524713000002
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+543.3%

Prior period

Unit12 478,000

2011-01-01 – 2011-12-31
Current period

Unit12 3.08 million

2012-01-01 – 2012-12-31

Exact inputs and evidence

3075000 − 478000 = 2597000 Unit12

478000 Unit12 · 2011-01-01 – 2011-12-31
Inspect prior input Prior source
3075000 Unit12 · 2012-01-01 – 2012-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · Obagi Medical Products, Inc. · 2012-12-31 Obagi Medical Products, Inc. (edgar:1375247) Year-over-year change in Capital expenditure: 2597000 Unit12 Concept: fundies:CapitalExpenditure Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T18:42:31Z Snapshot: 2fbca020a3b1a3920ec51a910fa98a0db8635d0ebbb06756403649f6e697ad49 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1375247?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 3075000 Unit12 (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1375247/000137524713000002/ompi-20121231.xml#1065350 Filing: 000137524713000002 Input fundies:CapitalExpenditure: 478000 Unit12 (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1375247/000137524713000002/ompi-20121231.xml#1065160 Filing: 000137524713000002
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2012 2012-01-01 – 2012-12-31

Revenue Unit12 120.68 million 100% of revenue
Cost of revenue Unit12 25.05 million 21% of revenue
Operating expenses Unit12 68.2 million 57% of revenue
Operating income Unit12 27.43 million 23% of revenue
Tax, interest and other Derived Unit12 10.79 million 8.9% of revenue
Net income Unit12 16.64 million 14% of revenue

Cash

Operating cash flow Unit12 20.42 million 17% of revenue
Capital expenditure Unit12 3.08 million 2.5% of revenue
Free cash flow Derived Unit12 17.35 million 14% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2009 11%82%
2010 86%
2011 86%
2012 14%77%

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2009 2009-01-01 – 2009-12-31	104096000	85668000 Derived	18428000	7095000 Derived	11333000	17974000 Derived	Source 2009-01-01 – 2009-12-31: 104096000 Unit12 Inspect Revenue Open source 2009-01-01 – 2009-12-31: 18428000 Unit12 Inspect Operating Income Open source 2009-01-01 – 2009-12-31: 11333000 Unit12 Inspect Net Income Open source 2009-01-01 – 2009-12-31: 18934000 Unit12 Inspect Operating Cash Flow Open source 2009-01-01 – 2009-12-31: 960000 Unit12 Inspect Capital Expenditure Open source
2010 2010-01-01 – 2010-12-31	112763000	96942000 Derived	15821000	6330000 Derived	9491000	14125000 Derived	Source 2010-01-01 – 2010-12-31: 112763000 Unit12 Inspect Revenue Open source 2010-01-01 – 2010-12-31: 15821000 Unit12 Inspect Operating Income Open source 2010-01-01 – 2010-12-31: 9491000 Unit12 Inspect Net Income Open source 2010-01-01 – 2010-12-31: 14476000 Unit12 Inspect Operating Cash Flow Open source 2010-01-01 – 2010-12-31: 351000 Unit12 Inspect Capital Expenditure Open source
2011 2011-01-01 – 2011-12-31	114108000	98102000 Derived	16006000	5986000 Derived	10020000	18914000 Derived	Source 2011-01-01 – 2011-12-31: 114108000 Unit12 Inspect Revenue Open source 2011-01-01 – 2011-12-31: 16006000 Unit12 Inspect Operating Income Open source 2011-01-01 – 2011-12-31: 10020000 Unit12 Inspect Net Income Open source 2011-01-01 – 2011-12-31: 19392000 Unit12 Inspect Operating Cash Flow Open source 2011-01-01 – 2011-12-31: 478000 Unit12 Inspect Capital Expenditure Open source
2012 2012-01-01 – 2012-12-31	120678000	93249000 Derived	27429000	10791000 Derived	16638000	17347000 Derived	Source 2012-01-01 – 2012-12-31: 120678000 Unit12 Inspect Revenue Open source 2012-01-01 – 2012-12-31: 27429000 Unit12 Inspect Operating Income Open source 2012-01-01 – 2012-12-31: 16638000 Unit12 Inspect Net Income Open source 2012-01-01 – 2012-12-31: 20422000 Unit12 Inspect Operating Cash Flow Open source 2012-01-01 – 2012-12-31: 3075000 Unit12 Inspect Capital Expenditure Open source

Amounts are exact, in Unit12.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Unit12 120.7M 2012

Values and sources

Revenue values and source evidence
Period	Series	Value(Unit12)	Source evidence
20092009-12-31	Revenue	104096000	Revenue: 104096000 Open source
20102010-12-31	Revenue	112763000	Revenue: 112763000 Open source
20112011-12-31	Revenue	114108000	Revenue: 114108000 Open source
20122012-12-31	Revenue	120678000	Revenue: 120678000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

5.8% 2012

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20092009-12-31	Year over year	No prior comparable period	Revenue: 104096000 Open source
20102010-12-31	Year over year	8.3%	Revenue: 112763000 Open source Revenue: 104096000 Open source
20112011-12-31	Year over year	1.2%	Revenue: 114108000 Open source Revenue: 112763000 Open source
20122012-12-31	Year over year	5.8%	Revenue: 120678000 Open source Revenue: 114108000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 22.7% 2012

Net margin 13.8% 2012

Free cash flow margin 14.4% 2012

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20092009-12-31	Operating margin	17.7%	Operating Income: 18428000 Open source Revenue: 104096000 Open source
20102010-12-31	Operating margin	14%	Operating Income: 15821000 Open source Revenue: 112763000 Open source
20112011-12-31	Operating margin	14%	Operating Income: 16006000 Open source Revenue: 114108000 Open source
20122012-12-31	Operating margin	22.7%	Operating Income: 27429000 Open source Revenue: 120678000 Open source
20092009-12-31	Net margin	10.9%	Net Income: 11333000 Open source Revenue: 104096000 Open source
20102010-12-31	Net margin	8.4%	Net Income: 9491000 Open source Revenue: 112763000 Open source
20112011-12-31	Net margin	8.8%	Net Income: 10020000 Open source Revenue: 114108000 Open source
20122012-12-31	Net margin	13.8%	Net Income: 16638000 Open source Revenue: 120678000 Open source
20092009-12-31	Free cash flow margin	17.3%	Revenue: 104096000 Open source Operating Cash Flow: 18934000 Open source Capital Expenditure: 960000 Open source
20102010-12-31	Free cash flow margin	12.5%	Revenue: 112763000 Open source Operating Cash Flow: 14476000 Open source Capital Expenditure: 351000 Open source
20112011-12-31	Free cash flow margin	16.6%	Revenue: 114108000 Open source Operating Cash Flow: 19392000 Open source Capital Expenditure: 478000 Open source
20122012-12-31	Free cash flow margin	14.4%	Revenue: 120678000 Open source Operating Cash Flow: 20422000 Open source Capital Expenditure: 3075000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

Unit12 20.4M 2012

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(Unit12)	Source evidence
20092009-12-31	Operating cash flow	18934000	Operating Cash Flow: 18934000 Open source
20102010-12-31	Operating cash flow	14476000	Operating Cash Flow: 14476000 Open source
20112011-12-31	Operating cash flow	19392000	Operating Cash Flow: 19392000 Open source
20122012-12-31	Operating cash flow	20422000	Operating Cash Flow: 20422000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Unit12 17.3M 2012

Values and sources

Free cash flow values and source evidence
Period	Series	Value(Unit12)	Source evidence
20092009-12-31	Free cash flow	17974000	Operating Cash Flow: 18934000 Open source Capital Expenditure: 960000 Open source
20102010-12-31	Free cash flow	14125000	Operating Cash Flow: 14476000 Open source Capital Expenditure: 351000 Open source
20112011-12-31	Free cash flow	18914000	Operating Cash Flow: 19392000 Open source Capital Expenditure: 478000 Open source
20122012-12-31	Free cash flow	17347000	Operating Cash Flow: 20422000 Open source Capital Expenditure: 3075000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

24.7% 2012

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2009-12-31	Liabilities / assets	Not reported	No source recorded
20102010-12-31	Liabilities / assets	23.1%	Total Liabilities: 14478000 Open source Total Assets: 62707000 Open source
20112011-12-31	Liabilities / assets	21.6%	Total Liabilities: 16779000 Open source Total Assets: 77651000 Open source
20122012-12-31	Liabilities / assets	24.7%	Total Liabilities: 20246000 Open source Total Assets: 82109000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

3.58× 2012

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2009-12-31	Current assets / current liabilities	Not reported	No source recorded
20102010-12-31	Current assets / current liabilities	3.8×	Current Assets: 48908000 Open source Current Liabilities: 12879000 Open source
20112011-12-31	Current assets / current liabilities	4.73×	Current Assets: 66471000 Open source Current Liabilities: 14059000 Open source
20122012-12-31	Current assets / current liabilities	3.58×	Current Assets: 65805000 Open source Current Liabilities: 18395000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2009 2009-01-01 – 2009-12-31	Unit12 11.33 million Exact value Exact value: 11333000 Unit12 2009-01-01 – 2009-12-31: 11333000 Unit12 Inspect Net Income Open source Share or cite Citation for Net Income · Obagi Medical Products, Inc. · 2009-12-31 Obagi Medical Products, Inc. (edgar:1375247) Net Income: 11333000 Unit12 Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T18:42:31Z Snapshot: 2fbca020a3b1a3920ec51a910fa98a0db8635d0ebbb06756403649f6e697ad49 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1375247/explain?concept=fundies%3ANetIncome&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=Unit12&dimensions= Input fundies:NetIncome: 11333000 Unit12 (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1375247/000137524712000038/ompi-20111231.xml#422251 Filing: 000137524712000038 The citation records this snapshot. The page link may show a newer release later.	Unit12 18.93 million Exact value Exact value: 18934000 Unit12 2009-01-01 – 2009-12-31: 18934000 Unit12 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Obagi Medical Products, Inc. · 2009-12-31 Obagi Medical Products, Inc. (edgar:1375247) Operating Cash Flow: 18934000 Unit12 Concept: fundies:OperatingCashFlow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T18:42:31Z Snapshot: 2fbca020a3b1a3920ec51a910fa98a0db8635d0ebbb06756403649f6e697ad49 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1375247/explain?concept=fundies%3AOperatingCashFlow&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=Unit12&dimensions= Input fundies:OperatingCashFlow: 18934000 Unit12 (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1375247/000137524712000038/ompi-20111231.xml#421675 Filing: 000137524712000038 The citation records this snapshot. The page link may show a newer release later.	Unit12 960,000 Exact value Exact value: 960000 Unit12 2009-01-01 – 2009-12-31: 960000 Unit12 Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Obagi Medical Products, Inc. · 2009-12-31 Obagi Medical Products, Inc. (edgar:1375247) Capital Expenditure: 960000 Unit12 Concept: fundies:CapitalExpenditure Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T18:42:31Z Snapshot: 2fbca020a3b1a3920ec51a910fa98a0db8635d0ebbb06756403649f6e697ad49 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1375247/explain?concept=fundies%3ACapitalExpenditure&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=Unit12&dimensions= Input fundies:CapitalExpenditure: 960000 Unit12 (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1375247/000137524712000038/ompi-20111231.xml#432491 Filing: 000137524712000038 The citation records this snapshot. The page link may show a newer release later.	Unit12 17.97 million Calculation and evidence 18934000 − 960000 Unit12 Exact free cash flow: 17974000 Unit12 2009-01-01 – 2009-12-31: 18934000 Unit12 · Inspect Operating Cash Flow · Source 2009-01-01 – 2009-12-31: 960000 Unit12 · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Obagi Medical Products, Inc. · 2009-12-31 Obagi Medical Products, Inc. (edgar:1375247) Free cash flow: 17974000 Unit12 Concept: free-cash-flow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T18:42:31Z Snapshot: 2fbca020a3b1a3920ec51a910fa98a0db8635d0ebbb06756403649f6e697ad49 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1375247?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 18934000 Unit12 (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1375247/000137524712000038/ompi-20111231.xml#421675 Filing: 000137524712000038 Input fundies:CapitalExpenditure: 960000 Unit12 (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1375247/000137524712000038/ompi-20111231.xml#432491 Filing: 000137524712000038 The citation records this snapshot. The page link may show a newer release later.
2010 2010-01-01 – 2010-12-31	Unit12 9.49 million Exact value Exact value: 9491000 Unit12 2010-01-01 – 2010-12-31: 9491000 Unit12 Inspect Net Income Open source Share or cite Citation for Net Income · Obagi Medical Products, Inc. · 2010-12-31 Obagi Medical Products, Inc. (edgar:1375247) Net Income: 9491000 Unit12 Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T18:42:31Z Snapshot: 2fbca020a3b1a3920ec51a910fa98a0db8635d0ebbb06756403649f6e697ad49 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1375247/explain?concept=fundies%3ANetIncome&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=Unit12&dimensions= Input fundies:NetIncome: 9491000 Unit12 (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1375247/000137524713000002/ompi-20121231.xml#1032594 Filing: 000137524713000002 The citation records this snapshot. The page link may show a newer release later.	Unit12 14.48 million Exact value Exact value: 14476000 Unit12 2010-01-01 – 2010-12-31: 14476000 Unit12 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Obagi Medical Products, Inc. · 2010-12-31 Obagi Medical Products, Inc. (edgar:1375247) Operating Cash Flow: 14476000 Unit12 Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T18:42:31Z Snapshot: 2fbca020a3b1a3920ec51a910fa98a0db8635d0ebbb06756403649f6e697ad49 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1375247/explain?concept=fundies%3AOperatingCashFlow&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=Unit12&dimensions= Input fundies:OperatingCashFlow: 14476000 Unit12 (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1375247/000137524713000002/ompi-20121231.xml#1031898 Filing: 000137524713000002 The citation records this snapshot. The page link may show a newer release later.	Unit12 351,000 Exact value Exact value: 351000 Unit12 2010-01-01 – 2010-12-31: 351000 Unit12 Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Obagi Medical Products, Inc. · 2010-12-31 Obagi Medical Products, Inc. (edgar:1375247) Capital Expenditure: 351000 Unit12 Concept: fundies:CapitalExpenditure Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T18:42:31Z Snapshot: 2fbca020a3b1a3920ec51a910fa98a0db8635d0ebbb06756403649f6e697ad49 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1375247/explain?concept=fundies%3ACapitalExpenditure&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=Unit12&dimensions= Input fundies:CapitalExpenditure: 351000 Unit12 (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1375247/000137524713000002/ompi-20121231.xml#1064970 Filing: 000137524713000002 The citation records this snapshot. The page link may show a newer release later.	Unit12 14.13 million Calculation and evidence 14476000 − 351000 Unit12 Exact free cash flow: 14125000 Unit12 2010-01-01 – 2010-12-31: 14476000 Unit12 · Inspect Operating Cash Flow · Source 2010-01-01 – 2010-12-31: 351000 Unit12 · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Obagi Medical Products, Inc. · 2010-12-31 Obagi Medical Products, Inc. (edgar:1375247) Free cash flow: 14125000 Unit12 Concept: free-cash-flow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T18:42:31Z Snapshot: 2fbca020a3b1a3920ec51a910fa98a0db8635d0ebbb06756403649f6e697ad49 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1375247?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 14476000 Unit12 (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1375247/000137524713000002/ompi-20121231.xml#1031898 Filing: 000137524713000002 Input fundies:CapitalExpenditure: 351000 Unit12 (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1375247/000137524713000002/ompi-20121231.xml#1064970 Filing: 000137524713000002 The citation records this snapshot. The page link may show a newer release later.
2011 2011-01-01 – 2011-12-31	Unit12 10.02 million Exact value Exact value: 10020000 Unit12 2011-01-01 – 2011-12-31: 10020000 Unit12 Inspect Net Income Open source Share or cite Citation for Net Income · Obagi Medical Products, Inc. · 2011-12-31 Obagi Medical Products, Inc. (edgar:1375247) Net Income: 10020000 Unit12 Concept: fundies:NetIncome Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T18:42:31Z Snapshot: 2fbca020a3b1a3920ec51a910fa98a0db8635d0ebbb06756403649f6e697ad49 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1375247/explain?concept=fundies%3ANetIncome&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=Unit12&dimensions= Input fundies:NetIncome: 10020000 Unit12 (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1375247/000137524713000002/ompi-20121231.xml#1032727 Filing: 000137524713000002 The citation records this snapshot. The page link may show a newer release later.	Unit12 19.39 million Exact value Exact value: 19392000 Unit12 2011-01-01 – 2011-12-31: 19392000 Unit12 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Obagi Medical Products, Inc. · 2011-12-31 Obagi Medical Products, Inc. (edgar:1375247) Operating Cash Flow: 19392000 Unit12 Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T18:42:31Z Snapshot: 2fbca020a3b1a3920ec51a910fa98a0db8635d0ebbb06756403649f6e697ad49 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1375247/explain?concept=fundies%3AOperatingCashFlow&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=Unit12&dimensions= Input fundies:OperatingCashFlow: 19392000 Unit12 (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1375247/000137524713000002/ompi-20121231.xml#1032130 Filing: 000137524713000002 The citation records this snapshot. The page link may show a newer release later.	Unit12 478,000 Exact value Exact value: 478000 Unit12 2011-01-01 – 2011-12-31: 478000 Unit12 Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Obagi Medical Products, Inc. · 2011-12-31 Obagi Medical Products, Inc. (edgar:1375247) Capital Expenditure: 478000 Unit12 Concept: fundies:CapitalExpenditure Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T18:42:31Z Snapshot: 2fbca020a3b1a3920ec51a910fa98a0db8635d0ebbb06756403649f6e697ad49 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1375247/explain?concept=fundies%3ACapitalExpenditure&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=Unit12&dimensions= Input fundies:CapitalExpenditure: 478000 Unit12 (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1375247/000137524713000002/ompi-20121231.xml#1065160 Filing: 000137524713000002 The citation records this snapshot. The page link may show a newer release later.	Unit12 18.91 million Calculation and evidence 19392000 − 478000 Unit12 Exact free cash flow: 18914000 Unit12 2011-01-01 – 2011-12-31: 19392000 Unit12 · Inspect Operating Cash Flow · Source 2011-01-01 – 2011-12-31: 478000 Unit12 · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Obagi Medical Products, Inc. · 2011-12-31 Obagi Medical Products, Inc. (edgar:1375247) Free cash flow: 18914000 Unit12 Concept: free-cash-flow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T18:42:31Z Snapshot: 2fbca020a3b1a3920ec51a910fa98a0db8635d0ebbb06756403649f6e697ad49 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1375247?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 19392000 Unit12 (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1375247/000137524713000002/ompi-20121231.xml#1032130 Filing: 000137524713000002 Input fundies:CapitalExpenditure: 478000 Unit12 (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1375247/000137524713000002/ompi-20121231.xml#1065160 Filing: 000137524713000002 The citation records this snapshot. The page link may show a newer release later.
2012 2012-01-01 – 2012-12-31	Unit12 16.64 million Exact value Exact value: 16638000 Unit12 2012-01-01 – 2012-12-31: 16638000 Unit12 Inspect Net Income Open source Share or cite Citation for Net Income · Obagi Medical Products, Inc. · 2012-12-31 Obagi Medical Products, Inc. (edgar:1375247) Net Income: 16638000 Unit12 Concept: fundies:NetIncome Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T18:42:31Z Snapshot: 2fbca020a3b1a3920ec51a910fa98a0db8635d0ebbb06756403649f6e697ad49 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1375247/explain?concept=fundies%3ANetIncome&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=Unit12&dimensions= Input fundies:NetIncome: 16638000 Unit12 (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1375247/000137524713000002/ompi-20121231.xml#1032861 Filing: 000137524713000002 The citation records this snapshot. The page link may show a newer release later.	Unit12 20.42 million Exact value Exact value: 20422000 Unit12 2012-01-01 – 2012-12-31: 20422000 Unit12 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Obagi Medical Products, Inc. · 2012-12-31 Obagi Medical Products, Inc. (edgar:1375247) Operating Cash Flow: 20422000 Unit12 Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T18:42:31Z Snapshot: 2fbca020a3b1a3920ec51a910fa98a0db8635d0ebbb06756403649f6e697ad49 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1375247/explain?concept=fundies%3AOperatingCashFlow&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=Unit12&dimensions= Input fundies:OperatingCashFlow: 20422000 Unit12 (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1375247/000137524713000002/ompi-20121231.xml#1032362 Filing: 000137524713000002 The citation records this snapshot. The page link may show a newer release later.	Unit12 3.08 million Exact value Exact value: 3075000 Unit12 2012-01-01 – 2012-12-31: 3075000 Unit12 Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Obagi Medical Products, Inc. · 2012-12-31 Obagi Medical Products, Inc. (edgar:1375247) Capital Expenditure: 3075000 Unit12 Concept: fundies:CapitalExpenditure Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T18:42:31Z Snapshot: 2fbca020a3b1a3920ec51a910fa98a0db8635d0ebbb06756403649f6e697ad49 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1375247/explain?concept=fundies%3ACapitalExpenditure&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=Unit12&dimensions= Input fundies:CapitalExpenditure: 3075000 Unit12 (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1375247/000137524713000002/ompi-20121231.xml#1065350 Filing: 000137524713000002 The citation records this snapshot. The page link may show a newer release later.	Unit12 17.35 million Calculation and evidence 20422000 − 3075000 Unit12 Exact free cash flow: 17347000 Unit12 2012-01-01 – 2012-12-31: 20422000 Unit12 · Inspect Operating Cash Flow · Source 2012-01-01 – 2012-12-31: 3075000 Unit12 · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Obagi Medical Products, Inc. · 2012-12-31 Obagi Medical Products, Inc. (edgar:1375247) Free cash flow: 17347000 Unit12 Concept: free-cash-flow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T18:42:31Z Snapshot: 2fbca020a3b1a3920ec51a910fa98a0db8635d0ebbb06756403649f6e697ad49 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1375247?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 20422000 Unit12 (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1375247/000137524713000002/ompi-20121231.xml#1032362 Filing: 000137524713000002 Input fundies:CapitalExpenditure: 3075000 Unit12 (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1375247/000137524713000002/ompi-20121231.xml#1065350 Filing: 000137524713000002 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

28 filings · 1,222 latest values · 1,222 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001375247, 1375247, edgar:1375247

Also known as Obagi Medical Products, Inc.

Obagi Medical Products, Inc.

Latest quarter

Revenue

Reported share-count change

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2012 2012-01-01 – 2012-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation